GeneOne Life Science Inc 011000
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 011000 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- KRW 2,405.00
- Day Range
- KRW 2,370.00–2,410.00
- 52-Week Range
- KRW 2,225.00–5,240.00
- Bid/Ask
- KRW 2,380.00 / KRW 2,400.00
- Market Cap
- KRW 189.99 Bil
- Volume/Avg
- 183,137 / 630,637
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.59
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
GeneOne Life Science Inc is engaged in the research, development, and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 78
- Website
- http://www.genels.com
Comparables
Valuation
|
Metric
|
011000
|
302440
|
206650
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 427.06 | 62.57 |
Price/Book Value | 1.67 | 2.70 | 4.49 |
Price/Sales | 4.59 | 12.40 | 6.69 |
Price/Cash Flow | — | 95.99 | 24.16 |
Price/Earnings
011000
302440
206650
Financial Strength
|
Metric
|
011000
|
302440
|
206650
|
|---|---|---|---|
Quick Ratio | — | 9.56 | 0.97 |
Current Ratio | 1.62 | 10.20 | 1.81 |
Interest Coverage | −65.27 | −3.45 | −13.01 |
Quick Ratio
011000
302440
206650
Profitability
|
Metric
|
011000
|
302440
|
206650
|
|---|---|---|---|
Return on Assets (Normalized) | −27.13% | 2.49% | 1.12% |
Return on Equity (Normalized) | −38.17% | 2.86% | 1.54% |
Return on Invested Capital (Normalized) | −30.62% | 2.26% | 1.88% |
Return on Assets
011000
302440
206650
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Jwvlcdzpw | Xwql | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Nmtbrxjj | Vprhq | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Ykjkyzwn | Mvkbs | $108.2 Bil | |
MRNA
| Moderna Inc | Zmpgwqsl | Dfw | $50.9 Bil | |
ARGX
| argenx SE ADR | Hzqwrsczz | Dmqp | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Jvbdtybfq | Jglr | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Gyfgvyhn | Shgwhm | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Rwdrdvx | Dvllgx | $14.6 Bil | |
INCY
| Incyte Corp | Nqhkvnrj | Nsjww | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Pwfzptvl | Skjntk | $12.3 Bil |